MICHAEL VASCONCELLES - 13 Sep 2024 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
/s/ Teresa Bair, Attorney-in-fact for Michael Vasconcelles
Issuer symbol
KURA
Transactions as of
13 Sep 2024
Net transactions value
$0
Form type
4
Filing time
17 Sep 2024, 16:10:02 UTC
Previous filing
12 Feb 2024
Next filing
06 Jun 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +52,000 $0.000000 52,000 13 Sep 2024 Common Stock 52,000 $20.88 Direct F1
transaction KURA Option to purchase common stock Award $0 +17,333 $0.000000 17,333 13 Sep 2024 Common Stock 17,333 $20.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in three equal annual installments commencing on the one year anniversary of the date of grant.
F2 This option vests in full on the one year anniversary of the date of grant.